Is bigger better when it comes to investing in marijuana stocks?
Two very different kinds of marijuana stocks. Which is the smarter pick for long-term investors?
They're the biggest. But which is the best?
Which big healthcare stock is the better pick for investors now?
They dominate their respective niche markets. And all three markets are growing rapidly.
A peek into the likely future for the big drugmaker.
Which stock wins in a battle between a beaten-down biotech and a booming big pharma company?
It's a matchup of small against big in this battle of Canadian marijuana stocks.
There was a flurry of earnings releases this week from leaders of the Canadian cannabis industry. Here are the winners and losers.
The Canadian marijuana stock erased most of the previous day's decline.
Great clinical results for its experimental hemophilia B gene therapy lit a fire beneath this biotech stock.
Disappointing quarterly results and a broader market pullback hurt the big Canadian marijuana stocks -- at least temporarily.
And why there's absolutely no reason for investors to worry about it.
If you could only buy one of these marijuana stocks, here's the better choice.
Forget the top- and bottom-line numbers. Here's what you should really pay attention to in Tilray's Q3 update.
Hint: Tremendous revenue growth wasn't one of them.
Jeff Sessions' Replacement Could Show Marijuana Stocks the Grass Isn't Always Greener on the Other Side
Don't count on improvement in the U.S. legal environment for the cannabis industry with a new attorney general.
Which stock wins in a matchup between these two big drugmakers?
This state didn't vote to legalize recreational marijuana, but it did the next best thing.
News of a much-anticipated acquisition deal sends the healthcare technology provider's shares higher.